Genetic Analysis AS
Genetic Analysis AS, a science-based diagnostic company, develops diagnostic solutions for human microbiome market in the United States, Europe, and internationally. It offers GA-map, a platform for the analysis of the human gut microbiota; GA-map Dysbiosis Test that detects and characterizes dysbiosis; and GA-map Analyzer, a cloud-based software solution. The company also provides GA-map Discove… Read more
Market Cap & Net Worth: Genetic Analysis AS (GEAN)
Genetic Analysis AS (ST:GEAN) has a market capitalization of $3.88 Million (Nkr44.22 Million) as of March 18, 2026. Listed on the ST stock exchange, this Sweden-based company holds position #34420 globally and #541 in its home market, demonstrating a -9.86% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Genetic Analysis AS's stock price Nkr0.64 by its total outstanding shares 69087041 (69.09 Million).
Genetic Analysis AS Market Cap History: 2025 to 2026
Genetic Analysis AS's market capitalization history from 2025 to 2026. Data shows growth from $4.24 Million to $3.88 Million (0.00% CAGR).
Genetic Analysis AS Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Genetic Analysis AS's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of GEAN by Market Capitalization
Companies near Genetic Analysis AS in the global market cap rankings as of March 18, 2026.
Key companies related to Genetic Analysis AS by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
Genetic Analysis AS Historical Marketcap From 2025 to 2026
Between 2025 and today, Genetic Analysis AS's market cap moved from $4.24 Million to $ 3.88 Million, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Nkr3.88 Million | -8.57% |
| 2025 | Nkr4.24 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Genetic Analysis AS was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.88 Million USD |
| MoneyControl | $3.88 Million USD |
| MarketWatch | $3.88 Million USD |
| marketcap.company | $3.88 Million USD |
| Reuters | $3.88 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.